• Pepstatin A: Precision Aspartic Protease Inhibitor in Resear

  2026-07-27

  Pepstatin A stands out as a benchmark aspartic protease inhibitor, empowering researchers to dissect viral protein processing and osteoclast differentiation with remarkable specificity. This guide unpacks experimental workflows, troubleshooting strategies, and innovations drawn from recent protocols, ensuring reproducible results with APExBIO’s ultra-pure Pepstatin A.

• Sulfaphenazole in Vascular Redox Biology: Mechanistic Insigh

  2026-07-26

  Explore the unique role of Sulfaphenazole as a CYP2C9 inhibitor in vascular endothelial research, oxidative stress reduction, and translational medicine. This article delivers mechanistic depth and protocol clarity not found in standard overviews.

• Zolmitriptan: 5-HT1B Agonist Insights for Migraine Research

  2026-07-25

  Zolmitriptan is a potent 5-HT1B receptor agonist widely utilized in migraine research. Its selectivity and solubility profile enable reliable serotonin receptor pharmacology studies. This dossier summarizes key pharmacological facts, validated workflows, and practical boundaries for laboratory implementation.

• Nanocrystal Formulation Enhances Ziprasidone HCl Permeabilit

  2026-07-24

  KARAKÜÇÜK et al. demonstrate that nanocrystal technology significantly increases the in vitro cellular permeability of ziprasidone hydrochloride monohydrate (ZHM) through Caco-2 monolayers, without inducing cytotoxicity. This finding addresses solubility-driven bioavailability challenges and informs advanced formulation strategies for both neuroscience and oncology research.

• GZMK+ CD8+ T Cells Drive Recurrence in Airway Inflammatory D

  2026-07-24

  A recent study identifies GZMK-expressing CD8+ T cells as a persistent, pathogenic subset promoting recurrence in airway inflammatory diseases, notably nasal polyps. These findings enhance mechanistic understanding of disease chronicity and suggest novel immunological targets for future intervention.

• I-BET151 (GSK1210151A): Targeting Super-Enhancers in Cancer

  2026-07-23

  Explore how I-BET151 (GSK1210151A) enables advanced dissection of super-enhancer-driven transcriptional programs and disulfidptosis in cancer biology. This in-depth analysis links molecular mechanism, protocol guidance, and the latest scientific breakthroughs, offering unique insights for innovative experimental design.

• Rosiglitazone (Brl-49653): Precision Tools for Adipose Brown

  2026-07-23

  Explore how Rosiglitazone (Brl-49653) enables advanced, mechanistically rigorous studies of adipose tissue browning, insulin sensitivity, and metabolic health. This article delves into nuanced assay design, the latest SETD7 findings, and practical protocols for translational type II diabetes research.

• Fluorescein Tyramide: Ultra-Sensitive Signal Amplification i

  2026-07-22

  Fluorescein Tyramide enables neuroscientists to visualize low-abundance targets and subtle circuit changes using ultra-sensitive signal amplification. Its robust performance in immunohistochemistry (IHC), in situ hybridization (ISH), and flow cytometry empowers translational research, especially in studies dissecting complex neurobehavioral mechanisms.

• A-769662: AMPK Activator Workflows for Energy Metabolism Res

  2026-07-22

  A-769662 is redefining precision AMPK activation for dissecting energy metabolism, lipid synthesis, and proteasome function in vitro and in vivo. Discover advanced workflows, protocol optimizations, and troubleshooting strategies that leverage APExBIO’s trusted compound to address emerging questions in autophagy and type 2 diabetes research.

• Mapping Metabolite Regulation of Human TET2 Dioxygenase by S

  2026-07-21

  Zhang et al. present a robust protocol integrating biochemical assays with saturation transfer difference (STD) NMR spectroscopy to systematically identify and validate metabolite binding to human TET2 dioxygenase. This approach advances the mechanistic understanding of how cellular metabolites modulate TET2 activity, offering a reproducible framework for studying the intersection of metabolism and epigenetic regulation.

• TCAIM-Mediated OGDH Regulation: A New Layer of Mitochondrial

  2026-07-21

  Wang et al. (2025) reveal TCAIM as a mitochondrial DNAJC co-chaperone that specifically binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, reshaping mitochondrial metabolism. This study highlights a non-classical, post-translational pathway for metabolic enzyme control, with broad implications for understanding cellular energy regulation.

• Ibuprofen Toxicology and Biodegradation: Environmental Chall

  2026-07-20

  Jan-Roblero and Cruz-Maya's 2023 review systematically examines ibuprofen's toxicological profile and its persistence in the environment, identifying the compound as an emerging contaminant with significant ecological risks. The paper highlights current biodegradation limitations and calls for more robust, bacteria-driven remediation approaches.

• Molecular Epidemiology and Resistance of C. auris in Guangzh

  2026-07-20

  This study provides a detailed genomic and phenotypic analysis of Candidozyma auris isolates from Guangzhou, revealing two predominant clades with distinct antifungal resistance and virulence traits. The findings advance understanding of C. auris transmission and support targeted infection control strategies in South China.

• Sitagliptin Phosphate Monohydrate: A Translational Lever for

  2026-07-19

  This thought-leadership article bridges mechanistic insights in DPP-4 inhibition with actionable strategies for translational researchers. It integrates key findings from recent gastrointestinal stretch and incretin hormone studies, positions Sitagliptin phosphate monohydrate (SKU A4036, APExBIO) as a pivotal research tool, and highlights protocol guidance, evidence-based workflow tips, and strategic outlooks for next-generation metabolic disease models.

• Calpain Inhibitor I, ALLN: Technical Guide for Research Work

  2026-07-18

  Calpain Inhibitor I, ALLN provides selective inhibition of calpains and cathepsins, supporting apoptosis assays and ischemia-reperfusion injury models requiring precise cysteine protease control. It is unsuitable for diagnostic or therapeutic applications, and not recommended for water-based protocols due to limited solubility.

451 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page